Home Articles Healing Stories Supplements Store Eldi Oils Store Get the Book & DVD
Who was Dr. Budwig?
Recommended Books
Share Your Recipes
How You Can Help
The Making of the DVD
In the Media
Contact Us
Life-saving! It clearly shows how a coffee enema, a cottage cheese and flaxseed oil mixture, etc...
Fabulous!!!! Easy to read, well organized, full of beneficial information...

Doctors link common chemotherapy drug to jawbone necrosis

 

Doctors at Long Island Jewish (LIJ) Medical Center recently discovered a link between a common chemotherapy drug and a serious bone disease called osteonecrosis of the jaw (ONJ). The discovery, published in the Journal of Oral and Maxillofacial Surgeons, prompted both the US Food and Drug Administration (FDA) and Novartis, the manufacturer of bisphosphonates used in cancer chemotherapy, to issue warnings earlier this fall to physicians and dentists about the risk for this potential adverse effect. ONJ is a condition in which the bone tissue in the jaw fails to heal after minor trauma such as a tooth extraction, causing the bone to be exposed. The exposure can eventually lead to infection and fracture and may require long-term antibiotic therapy or surgery to remove the dying bone tissue.

The chief of the Division of Oral and Maxillofacial Surgery at LIJ, Salvatore Ruggiero, DMD, MD, and his staff reported that they were struck by a cluster of cancer patients with necrotic lesions in the jaw — a condition they rarely saw, in only about one to two patients a year. When they launched a study of patients’ charts, they found that 63 patients diagnosed with this condition over a three-year period shared only one common clinical feature: they had all received long-term bisphosphonate therapy.

Read full article at: http://www.innovations-report.com


 

©2010 UEscher Productions. All Rights Reserved.